
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.740 | 7.490 | 5.750 |
Shares | 98.720 | 98.720 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 11.441 | 12.909 |
Price to Book | 2.126 | 1.794 |
Price to Sales | 0.929 | 1.168 |
Price to Cash Flow | 6.329 | 7.615 |
Dividend Yield | 4.082 | 3.039 |
5 Years Earnings Growth | 6.936 | 9.477 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 21.310 | 15.089 |
Technology | 19.170 | 14.126 |
Consumer Defensive | 15.380 | 9.861 |
Industrials | 10.660 | 12.314 |
Financial Services | 8.530 | 18.922 |
Communication Services | 8.070 | 8.071 |
Utilities | 5.900 | 4.481 |
Consumer Cyclical | 5.370 | 10.000 |
Basic Materials | 3.500 | 5.298 |
Energy | 1.180 | 5.479 |
Real Estate | 0.940 | 2.239 |
Number of long holdings: 99
Number of short holdings: 4
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UnitedHealth | US91324P1021 | 2.01 | 308.55 | +0.32% | |
AbbVie | US00287Y1091 | 1.92 | 189.28 | -0.77% | |
J&J | US4781601046 | 1.87 | 156.01 | +0.29% | |
Pfizer | US7170811035 | 1.73 | 25.38 | +0.24% | |
Cisco | US17275R1023 | 1.71 | 69.37 | +1.14% | |
Bristol-Myers Squibb | US1101221083 | 1.67 | 46.92 | -1.49% | |
Amgen | US0311621009 | 1.66 | 298.24 | +0.47% | |
Broadcom | US11135F1012 | 1.66 | 275.18 | +1.96% | |
Roche Holding Participation | CH0012032048 | 1.65 | 260.00 | +0.93% | |
Microsoft | US5949181045 | 1.62 | 498.84 | +1.58% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
US Large Cap Growth Fund Class A EU | 1.94B | 33.75 | 10.07 | 15.37 | ||
US Large Cap Growth Fund Class GA E | 1.94B | 33.96 | 10.28 | 15.61 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review